市場調査レポート
商品コード
1309736

臨床化学分析装置の世界市場:製品別 (全自動分析装置、PoC分析装置、試薬)・検査の種類別 (基礎代謝、肝臓、腎臓、脂質、甲状腺機能)・エンドユーザー別 (病院・診療所、検査室、研究機関)・地域別の将来予測 (2028年まで)

Clinical Chemistry Analyzers Market by Product (Fully-automated and PoC Analyzers, Reagents), Test Type (Basic Metabolic, Liver, Renal, Lipid, Thyroid Function), End User (Hospitals, Clinics, Laboratories, Research) & Region - Global Forecast to 2028

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 185 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.11円
臨床化学分析装置の世界市場:製品別 (全自動分析装置、PoC分析装置、試薬)・検査の種類別 (基礎代謝、肝臓、腎臓、脂質、甲状腺機能)・エンドユーザー別 (病院・診療所、検査室、研究機関)・地域別の将来予測 (2028年まで)
出版日: 2023年07月11日
発行: MarketsandMarkets
ページ情報: 英文 185 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の臨床化学分析装置の市場規模は、2023年の130億米ドルから2028年には165億米ドルに達し、予測期間中に4.9%のCAGRで成長すると予測されています。

主な成長促進要因としては、高齢者人口の増加、慢性疾患や生活習慣病の有病率の上昇などが挙げられます。また、PoC検査機器の採用や検査室自動化需要の高まりも市場拡大に寄与しています。しかし、高い設備投資の必要性、熟練した臨床検査技師の不足、再生品の存在といった課題によって、市場の成長は抑制される可能性があります。これらの要因により、当面の市場成長は緩やかになると予想されます。

"試薬が、予測期間中に製品別で最も高い成長率となる"

臨床化学分析装置市場を製品別に見ると、2022年に最も高い成長率を示したのは試薬部門でした。この成長は、分析装置に比べ大量に必要とされる試薬の大幅な需要に起因しています。試薬の継続的なニーズと繰り返し購入が、この部門の大幅な市場成長に寄与しています。

"脂質プロファイル検査分野が、最も高いCAGRで成長する"

臨床化学分析装置市場を検査の種類別に見ると、2022年には脂質プロファイル検査分野が最も高い成長率を示しました。この部門の成長は、世界の肥満率の上昇とそれに伴う肥満関連疾患の増加に起因しています。

"病院・診療所が、CAGRが最も高くなる"

臨床化学分析装置市場をエンドユーザー別に見ると、2022年には病院・診療所が最も高い成長率を示しました。この成長の背景には、疾病や障害の増加による病院数の世界の増加などがあります。さらに、病院・診療所での分析装置の普及や技術進歩が、臨床化学分析装置市場における同分野の著しい成長に寄与しています。

"アジア太平洋:最も急成長している地域"

世界の臨床化学分析装置市場を地域別に見ると、アジア太平洋地域は予測期間中に最も高いCAGRを示すと予測されています。この地域の成長は、主に中国や日本などの国々が牽引しています。

アジア太平洋地域における臨床化学分析装置市場の成長にはいくつかの要因が寄与しています。第一に、高齢者人口の増加と慢性疾患の負担増が、高度な診断ソリューションに対する大きな需要を生み出しています。次に、一人当たり所得の増加や医療インフラの整備が臨床化学分析装置の普及を後押ししています。

さらに、主要な市場関係者は医療産業に多額の投資を行っており、これが市場の成長をさらに後押ししています。最先端技術に対する需要の高まりや、アジア太平洋地域のさまざまな国々で民間病院が農村部に進出していることも、市場拡大に寄与しています。さらに、この地域では病院や診療所の数が増加しており、人口の医療ニーズの高まりが臨床化学分析装置の需要増につながっています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
  • 価格分析
  • 特許分析
  • バリューチェーン分析
  • サプライチェーン分析
  • エコシステム分析
  • ポーターのファイブフォース分析
  • PESTLE分析
  • 規制分析
  • 貿易分析

第6章 臨床化学分析装置市場:製品別

  • イントロダクション
  • 試薬
  • 分析装置
    • 半自動分析装置
    • 全自動分析装置
    • PoC分析装置
  • その他の製品

第7章 臨床化学分析装置市場:検査の種類別

  • イントロダクション
  • 基礎代謝パネル
  • 肝臓パネル
  • 腎臓プロファイル
  • 脂質プロファイル
  • 甲状腺機能パネル
  • 電解質パネル
  • 特殊化学検査

第8章 臨床化学分析装置市場:エンドユーザー別

  • イントロダクション
  • 病院・診療所
  • 診断検査室
  • 研究室・研究機関
  • その他のエンドユーザー

第9章 臨床化学分析装置市場:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • ロシア
    • その他の欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • その他のアジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第10章 競合情勢

  • 概要
  • 主要企業が採用した戦略
  • 上位企業の収益シェア分析
  • 市場シェア分析
  • 企業評価クアドラント
  • スタートアップの企業評価クアドラント (2022年)
  • 競合シナリオ

第11章 企業プロファイル

  • 主要企業
    • F. HOFFMANN-LA ROCHE LTD.
    • DANAHER CORPORATION
    • ABBOTT LABORATORIES
    • SIEMENS HEALTHCARE GMBH
    • THERMO FISHER SCIENTIFIC INC.
    • HORIBA, LTD.
    • SYSMEX CORPORATION
    • EKF DIAGNOSTICS
    • QUIDELORTHO CORPORATION
    • HITACHI LTD.
  • その他の企業
    • MINDRAY MEDICAL INTERNATIONAL LTD.
    • ELITECH GROUP
    • BIOBASE GROUP
    • SFRI
    • TRIVITRON HEALTHCARE PVT. LTD.
    • RANDOX LABORATORIES LTD.
    • MEDICA CORPORATION
    • MERIL LIFE SCIENCES PVT. LTD.
    • ERBA MANNHEIM
    • GENRUI BIOTECH CO., LTD.
    • DIRUI
    • TECO DIAGNOSTICS
    • BALIO DIAGNOSTICS
    • SNIBE CO. LTD.
    • AMS ALLIANCE

第12章 付録

目次
Product Code: MD 2843

The global clinical chemistry analyzers market size is projected to reach USD 16.5 billion by 2028 from USD 13.0 billion in 2023, at a CAGR of 4.9% during the forecast period. The clinical chemistry analyzers market is witnessing growth due to various factors. Key drivers include the increasing geriatric population and the rising prevalence of chronic and lifestyle diseases. Additionally, the adoption of Point-of-Care testing devices and the growing demand for laboratory automation contribute to market expansion. However, market growth may be constrained by challenges such as high capital investment requirements, a shortage of skilled clinical laboratory technicians, and the presence of refurbished products. These factors are anticipated to moderate the market's growth in the foreseeable future.

"The reagents accounted for the highest growth rate in the clinical chemistry analyzers market, by product, during the forecast period"

In the clinical chemistry analyzers market, the segments include analyzers, reagents, and other products. The reagents segment exhibited the highest growth rate in 2022. This growth can be attributed to the substantial demand for reagents, which are required in larger quantities compared to analyzers. The continuous need for reagents and repeat purchases contribute to the significant market growth of this segment.

"Lipid profile tests segment accounted for the highest CAGR"

The clinical chemistry analyzers market is categorized based on test types, including basic metabolic panels, electrolyte panels, liver panels, lipid profiles, renal profiles, thyroid function panels, and specialty chemical tests. In 2022, the lipid profile tests segment exhibited the highest growth rate. The growth of this segment can be attributed to the escalating obesity rates globally and the subsequent increase in obesity-related diseases. These factors significantly drive the demand for lipid profile tests, contributing to the robust growth of this segment in the clinical chemistry analyzers market.

"Hospitals and clinics segment accounted for the highest CAGR"

The clinical chemistry analyzers market is segmented based on end-users, including hospitals and clinics, diagnostic laboratories, research laboratories and institutes, and other end users. In 2022, the hospitals and clinics segment exhibited the highest growth rate. This growth can be attributed to several factors, such as the global increase in the number of hospitals due to the rising incidences of diseases and disorders. Additionally, the growing adoption of analyzers in hospital and clinic settings, coupled with advancements in technology, has contributed to the significant growth of this segment in the clinical chemistry analyzers market.

"Asia Pacific: The fastest-growing region clinical chemistry analyzers market"

The global clinical chemistry analyzers market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa regions. Among these, the Asia Pacific region is anticipated to exhibit the highest compound annual growth rate (CAGR) during the forecast period. The growth in this region is primarily driven by countries like China and Japan.

Several factors contribute to the growth of the clinical chemistry analyzers market in the Asia Pacific region. Firstly, the rising geriatric population and the increasing burden of chronic diseases create a significant demand for advanced diagnostic solutions. Secondly, the growing per capita income and improving healthcare infrastructure in countries across the region support the adoption of clinical chemistry analyzers.

Moreover, key market players are making substantial investments in the healthcare industry, which further fuels the growth of the market. The increasing demand for cutting-edge technologies and the expansion of private-sector hospitals into rural areas in various countries in the Asia Pacific region also contribute to market expansion. Additionally, the rising number of hospitals and clinics in the region addresses the growing healthcare needs of the population, resulting in increased demand for clinical chemistry analyzers.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
  • By Designation: C-level - 27%, D-level - 18%, and Others - 55%
  • By Region: North America - 51%, Europe - 21%, Asia Pacific - 18% and Latin America 6% and Middle East & Africa 4%

Prominent companies are F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Abbott Laboratories (US), Thermo Fisher Scientific Inc. (US), Siemens AG (Germany), HORIBA Ltd. (Japan), Sysmex Corporation (Japan), HITACHI (Japan), EKF Diagnostics (UK), Ortho Clinical Diagnostics (US), ELITech Group (France), Mindray Medical International Ltd. (China), BIOBASE Group (China), SFRI Medical Diagnostics (France), Trivitron Healthcare Pvt. Ltd. (India), Randox Laboratories Ltd. (UK), Medica Corporation (US), Meril Life Sciences Pvt. Ltd. (India), Erba Mannheim (UK), Genrui Biotech Inc. (China), DIRUI Industrial Co. Ltd. (China), Teco Diagnostics (US), Balio Diagnostics (France), Snibe Co. Ltd. (China) and AMS Alliance (Italy).

Research Coverage:

This research report categorizes the clinical chemistry analyzers market by product, test type, end user, and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the clinical chemistry analyzers market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; Contracts, partnerships, agreements, new product & service launches, mergers and acquisitions, and recent developments associated with the clinical chemistry analyzers market. Competitive analysis of upcoming startups in the clinical chemistry analyzers market ecosystem is covered in this report.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall clinical chemistry analyzers market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

  • Analysis of key drivers, restraints, opportunities, and challenges influencing the growth of the clinical chemistry analyzers market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the clinical chemistry analyzers market.
  • Market Development: Comprehensive information about lucrative markets - the report analyses the clinical chemistry analyzers market across varied regions.
  • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the clinical chemistry analyzers market.
  • Competitive Assessment: In-depth assessment of market ranking, growth strategies and service offerings of leading players like F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Abbott Laboratories (US), Thermo Fisher Scientific Inc. (US), Siemens AG (Germany), among others in the clinical chemistry analyzers market strategies.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
    • 1.2.2 MARKETS COVERED
    • FIGURE 1 CLINICAL CHEMISTRY ANALYZERS MARKET SEGMENTATION
    • 1.2.3 GEOGRAPHIC SCOPE
    • 1.2.4 YEARS CONSIDERED
  • 1.3 CURRENCY
  • 1.4 LIMITATIONS
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES
    • 1.6.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
  • 2.2 RESEARCH APPROACH
    • FIGURE 2 CLINICAL CHEMISTRY ANALYZERS MARKET: RESEARCH DESIGN METHODOLOGY
    • 2.2.1 SECONDARY DATA
      • 2.2.1.1 Key data from secondary sources
    • 2.2.2 PRIMARY DATA
      • 2.2.2.1 Primary sources
      • 2.2.2.2 Key data from primary sources
      • 2.2.2.3 Key industry insights
      • 2.2.2.4 Breakdown of primary interviews
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.3 MARKET SIZE ESTIMATION
    • 2.3.1 BOTTOM-UP APPROACH
      • 2.3.1.1 Approach 1: Company revenue estimation approach
    • FIGURE 5 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
      • 2.3.1.2 Approach 2: Presentations of companies and primary interviews
      • 2.3.1.3 Growth forecast
      • 2.3.1.4 CAGR projections
    • FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    • 2.3.2 TOP-DOWN APPROACH
    • FIGURE 7 CLINICAL CHEMISTRY ANALYZERS MARKET: TOP-DOWN APPROACH
  • 2.4 MARKET BREAKDOWN & DATA TRIANGULATION
    • FIGURE 8 DATA TRIANGULATION METHODOLOGY
  • 2.5 MARKET SHARE ANALYSIS
  • 2.6 STUDY ASSUMPTIONS
  • 2.7 RISK ASSESSMENT
    • TABLE 1 CLINICAL CHEMISTRY ANALYZERS MARKET: RISK ASSESSMENT
  • 2.8 LIMITATIONS
  • 2.9 CLINICAL CHEMISTRY ANALYZERS MARKET: RECESSION IMPACT

3 EXECUTIVE SUMMARY

    • FIGURE 9 CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
    • FIGURE 10 CLINICAL CHEMISTRY ANALYZERS MARKET, BY ANALYZER TYPE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 11 CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 12 CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    • FIGURE 13 CLINICAL CHEMISTRY ANALYZERS MARKET, BY REGION, 2023 VS. 2028 (USD MILLION)

4 PREMIUM INSIGHTS

  • 4.1 CLINICAL CHEMISTRY ANALYZERS MARKET OVERVIEW
    • FIGURE 14 RISING ADOPTION OF POC PRODUCTS TO SUPPORT MARKET GROWTH DURING FORECAST PERIOD
  • 4.2 CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2023 VS. 2028
    • FIGURE 15 REAGENTS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • 4.3 CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2023 VS. 2028
    • FIGURE 16 BASIC METABOLIC PANEL SEGMENT TO HOLD LARGEST SHARE DURING FORECAST PERIOD
  • 4.4 CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2023 VS. 2028
    • FIGURE 17 HOSPITALS & CLINICS SEGMENT TO CONTINUE TO DOMINATE MARKET DURING FORECAST PERIOD
  • 4.5 CLINICAL CHEMISTRY ANALYZERS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 18 ASIA PACIFIC MARKET EXPECTED TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 19 CLINICAL CHEMISTRY ANALYZERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising geriatric population and increasing prevalence of chronic & lifestyle diseases
    • TABLE 2 PERCENTAGE OF POPULATION AGED 65 YEARS OR ABOVE, BY REGION (2022-2050)
      • 5.2.1.2 Growing adoption of point-of-care testing devices
      • 5.2.1.3 Increasing demand for laboratory automation
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Requirement for high capital investments and shortage of skilled laboratory technicians
      • 5.2.2.2 Availability of refurbished analyzers
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Increasing government initiatives and funding for preventive care
      • 5.2.3.2 Growth opportunities in emerging economies
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Increasing regulatory requirements
      • 5.2.4.2 High degree of consolidation
  • 5.3 PRICING ANALYSIS
    • TABLE 3 AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT
  • 5.4 PATENT ANALYSIS
    • FIGURE 20 PATENT ANALYSIS FOR CLINICAL CHEMISTRY ANALYZERS (JANUARY 2013-DECEMBER 2022)
  • 5.5 VALUE CHAIN ANALYSIS
    • FIGURE 21 VALUE CHAIN ANALYSIS OF CLINICAL CHEMISTRY ANALYZERS MARKET
  • 5.6 SUPPLY CHAIN ANALYSIS
    • FIGURE 22 CLINICAL CHEMISTRY ANALYZERS MARKET: SUPPLY CHAIN ANALYSIS
  • 5.7 ECOSYSTEM ANALYSIS
    • FIGURE 23 CLINICAL CHEMISTRY ANALYZERS MARKET: ECOSYSTEM ANALYSIS
  • 5.8 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 4 CLINICAL CHEMISTRY ANALYZERS MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.8.1 THREAT OF NEW ENTRANTS
    • 5.8.2 THREAT OF SUBSTITUTES
    • 5.8.3 BARGAINING POWER OF SUPPLIERS
    • 5.8.4 BARGAINING POWER OF BUYERS
    • 5.8.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.9 PESTLE ANALYSIS
  • 5.10 REGULATORY ANALYSIS
    • 5.10.1 NORTH AMERICA
      • 5.10.1.1 US
      • 5.10.1.2 Canada
    • 5.10.2 EUROPE
    • 5.10.3 ASIA PACIFIC
      • 5.10.3.1 China
      • 5.10.3.2 Japan
      • 5.10.3.3 India
    • 5.10.4 LATIN AMERICA
      • 5.10.4.1 Brazil
      • 5.10.4.2 Mexico
    • 5.10.5 MIDDLE EAST
    • 5.10.6 AFRICA
  • 5.11 TRADE ANALYSIS
    • TABLE 5 IMPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 6 EXPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2018-2022 (USD MILLION)

6 CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 7 CLINICAL CHEMISTRY REAGENTS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • 6.2 REAGENTS
    • 6.2.1 RECURRENT PURCHASE REQUIREMENT OF REAGENTS TO DRIVE MARKET
    • TABLE 8 KEY PRODUCTS IN CLINICAL CHEMISTRY ANALYZERS REAGENTS MARKET
    • TABLE 9 CLINICAL CHEMISTRY REAGENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.3 ANALYZERS
    • TABLE 10 CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 11 CLINICAL CHEMISTRY ANALYZERS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.3.1 SEMI-AUTOMATIC ANALYZERS
      • 6.3.1.1 Cost-effectiveness of semi-automatic analyzers to propel segment growth
    • TABLE 12 KEY PRODUCTS IN SEMI-AUTOMATIC CLINICAL CHEMISTRY ANALYZERS MARKET
    • TABLE 13 SEMI-AUTOMATIC ANALYZERS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.3.2 FULLY AUTOMATIC ANALYZERS
      • 6.3.2.1 Rapid sample processing and reduction of turnaround times to boost market
    • TABLE 14 KEY PRODUCTS IN FULLY AUTOMATIC CLINICAL CHEMISTRY ANALYZERS MARKET
    • TABLE 15 FULLY AUTOMATIC ANALYZERS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.3.3 POINT-OF-CARE ANALYZERS
      • 6.3.3.1 Increasing adoption of PoC technologies to drive segment growth
    • TABLE 16 KEY PRODUCTS IN POINT-OF-CARE CLINICAL CHEMISTRY ANALYZERS MARKET
    • TABLE 17 POINT-OF-CARE ANALYZERS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.4 OTHER PRODUCTS
    • TABLE 18 CLINICAL CHEMISTRY ANALYZERS FOR OTHER PRODUCTS MARKET, BY REGION, 2021-2028 (USD MILLION)

7 CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE

  • 7.1 INTRODUCTION
    • TABLE 19 CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
  • 7.2 BASIC METABOLIC PANEL
    • 7.2.1 RISING INCIDENCE OF DIABETES AND OTHER CHRONIC DISEASES TO DRIVE MARKET
    • TABLE 20 CLINICAL CHEMISTRY BASIC METABOLIC PANEL TESTS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 7.3 LIVER PANEL
    • 7.3.1 INCREASE IN LIVER-RELATED DISEASES TO DRIVE MARKET
    • TABLE 21 CLINICAL CHEMISTRY LIVER PANEL TESTS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 7.4 RENAL PROFILE
    • 7.4.1 RISING INCIDENCE OF ESRD PATIENTS TO PROPEL GROWTH OF RENAL PROFILE TESTING MARKET
    • TABLE 22 CLINICAL CHEMISTRY RENAL PROFILE TESTS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 7.5 LIPID PROFILE
    • 7.5.1 RAPID RISE IN OBESITY RATES TO PROPEL MARKET GROWTH
    • TABLE 23 CLINICAL CHEMISTRY LIPID PROFILE TESTS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 7.6 THYROID FUNCTION PANEL
    • 7.6.1 SPIKE IN INCIDENCE OF THYROID-RELATED DISORDERS TO DRIVE MARKET
    • TABLE 24 CLINICAL CHEMISTRY THYROID FUNCTION PANEL TESTS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 7.7 ELECTROLYTE PANEL
    • 7.7.1 INCREASING PREVALENCE OF HYPERTENSION AND KIDNEY DISEASES TO DRIVE GROWTH
    • TABLE 25 CLINICAL CHEMISTRY ELECTROLYTE PANEL TESTS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 7.8 SPECIALTY CHEMICAL TESTS
    • 7.8.1 SPECIALTY CHEMICAL TESTS SEGMENT TO GROW AT LOWEST CAGR DURING FORECAST PERIOD
    • TABLE 26 CLINICAL CHEMISTRY SPECIALTY CHEMICAL TESTS MARKET, BY REGION, 2021-2028 (USD MILLION)

8 CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER

  • 8.1 INTRODUCTION
    • TABLE 27 CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 8.2 HOSPITALS & CLINICS
    • 8.2.1 INCREASE IN DISEASES & DISORDERS TO PROPEL MARKET GROWTH
    • TABLE 28 CLINICAL CHEMISTRY ANALYZERS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2021-2028 (USD MILLION)
  • 8.3 DIAGNOSTIC LABORATORIES
    • 8.3.1 RISE IN OUTSOURCING ACTIVITIES TO DIAGNOSTIC LABORATORIES AT REDUCED COSTS TO DRIVE MARKET
    • TABLE 29 CLINICAL CHEMISTRY ANALYZERS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2021-2028 (USD MILLION)
  • 8.4 RESEARCH LABORATORIES & INSTITUTES
    • 8.4.1 GROWTH IN FUNDING FOR LIFE SCIENCE RESEARCH TO BOOST MARKET
    • TABLE 30 CLINICAL CHEMISTRY ANALYZERS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2021-2028 (USD MILLION)
  • 8.5 OTHER END USERS
    • TABLE 31 CLINICAL CHEMISTRY ANALYZERS MARKET FOR OTHER END USERS, BY REGION, 2021-2028 (USD MILLION)

9 CLINICAL CHEMISTRY ANALYZERS MARKET, BY REGION

  • 9.1 INTRODUCTION
    • TABLE 32 CLINICAL CHEMISTRY ANALYZERS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 9.2 NORTH AMERICA
    • FIGURE 24 NORTH AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET SNAPSHOT
    • TABLE 33 NORTH AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 34 NORTH AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 35 NORTH AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 36 NORTH AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 37 NORTH AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.2.1 US
      • 9.2.1.1 Increasing cases of diabetes & obesity-related diseases to boost market
    • TABLE 38 US: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 39 US: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 40 US: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 41 US: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.2.2 CANADA
      • 9.2.2.1 Spike in prevalence of chronic & lifestyle diseases to drive market growth in Canada
    • TABLE 42 CANADA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 43 CANADA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 44 CANADA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 45 CANADA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.3 EUROPE
    • TABLE 46 EUROPE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 47 EUROPE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 48 EUROPE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 49 EUROPE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 50 EUROPE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.3.1 GERMANY
      • 9.3.1.1 Increasing healthcare expenditure to drive market growth in Germany
    • TABLE 51 GERMANY: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 52 GERMANY: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 53 GERMANY: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 54 GERMANY: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.3.2 UK
      • 9.3.2.1 Growing number of accredited clinical laboratories to propel market growth
    • TABLE 55 UK: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 56 UK: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 57 UK: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 58 UK: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.3.3 FRANCE
      • 9.3.3.1 Rising R&D expenditure in France to boost market
    • TABLE 59 FRANCE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 60 FRANCE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 61 FRANCE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 62 FRANCE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.3.4 ITALY
      • 9.3.4.1 Age-related chronic conditions owing to large geriatric population to drive market growth
    • TABLE 63 ITALY: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 64 ITALY: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 65 ITALY: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 66 ITALY: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.3.5 SPAIN
      • 9.3.5.1 Increasing prevalence of age-associated disorders to drive market growth
    • TABLE 67 SPAIN: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 68 SPAIN: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 69 SPAIN: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 70 SPAIN: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.3.6 RUSSIA
      • 9.3.6.1 Increasing access to quality healthcare to support market growth in Russia
    • TABLE 71 RUSSIA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 72 RUSSIA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 73 RUSSIA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 74 RUSSIA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.3.7 REST OF EUROPE
    • TABLE 75 REST OF EUROPE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 76 REST OF EUROPE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 77 REST OF EUROPE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 78 REST OF EUROPE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • FIGURE 25 ASIA PACIFIC: CLINICAL CHEMISTRY ANALYZERS MARKET SNAPSHOT
    • TABLE 79 ASIA PACIFIC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 80 ASIA PACIFIC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 81 ASIA PACIFIC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 82 ASIA PACIFIC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 83 ASIA PACIFIC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.4.1 CHINA
      • 9.4.1.1 Increasing awareness of preventive care to drive demand for clinical chemistry analyzers
    • TABLE 84 CHINA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 85 CHINA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 86 CHINA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 87 CHINA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.4.2 JAPAN
      • 9.4.2.1 Favorable regulatory framework to drive market growth in Japan
    • TABLE 88 JAPAN: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 89 JAPAN: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 90 JAPAN: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 91 JAPAN: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.4.3 INDIA
      • 9.4.3.1 Increasing private & public investments to propel market growth
    • TABLE 92 INDIA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 93 INDIA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 94 INDIA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 95 INDIA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.4.4 REST OF ASIA PACIFIC
    • TABLE 96 REST OF ASIA PACIFIC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 97 REST OF ASIA PACIFIC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 98 REST OF ASIA PACIFIC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 99 REST OF ASIA PACIFIC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.5 LATIN AMERICA
    • TABLE 100 LATIN AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 101 LATIN AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 102 LATIN AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 103 LATIN AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.6 MIDDLE EAST & AFRICA
    • TABLE 104 MIDDLE EAST & AFRICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 105 MIDDLE EAST & AFRICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 106 MIDDLE EAST & AFRICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 107 MIDDLE EAST & AFRICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2021-2028 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 STRATEGIES ADOPTED BY KEY PLAYERS
    • 10.2.1 RIGHT-TO-WIN APPROACHES ADOPTED BY PLAYERS
    • TABLE 108 CLINICAL CHEMISTRY ANALYZERS MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
  • 10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
    • FIGURE 26 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN CLINICAL CHEMISTRY MARKET (2022)
  • 10.4 MARKET SHARE ANALYSIS
    • FIGURE 27 MARKET SHARE ANALYSIS OF KEY PLAYERS (2022)
    • TABLE 109 CLINICAL CHEMISTRY ANALYZERS MARKET: DEGREE OF COMPETITION
  • 10.5 COMPANY EVALUATION QUADRANT
    • 10.5.1 LIST OF EVALUATED VENDORS
    • 10.5.2 STARS
    • 10.5.3 EMERGING LEADERS
    • 10.5.4 PERVASIVE PLAYERS
    • 10.5.5 PARTICIPANTS
    • FIGURE 28 CLINICAL CHEMISTRY ANALYZERS MARKET: COMPANY EVALUATION MATRIX, 2022
  • 10.6 COMPANY EVALUATION QUADRANT FOR START-UPS (2022)
    • 10.6.1 PROGRESSIVE COMPANIES
    • 10.6.2 STARTING BLOCKS
    • 10.6.3 RESPONSIVE COMPANIES
    • 10.6.4 DYNAMIC COMPANIES
    • FIGURE 29 CLINICAL CHEMISTRY ANALYZERS MARKET: COMPANY EVALUATION MATRIX FOR START-UPS, 2022
  • 10.7 COMPETITIVE SCENARIO
    • 10.7.1 PRODUCT LAUNCHES & APPROVALS
    • TABLE 110 KEY PRODUCT LAUNCHES & APPROVALS
    • 10.7.2 DEALS
    • TABLE 111 KEY DEALS
    • 10.7.3 OTHER DEVELOPMENTS
    • TABLE 112 KEY OTHER DEVELOPMENTS

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
  • (Business overview, Products offered, Recent developments, Product launches, MnM view, Key strengths, Strategic choices, and Weaknesses & competitive threats)**
    • 11.1.1 F. HOFFMANN-LA ROCHE LTD.
    • TABLE 113 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
    • FIGURE 30 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022)
    • 11.1.2 DANAHER CORPORATION
    • TABLE 114 DANAHER CORPORATION: BUSINESS OVERVIEW
    • FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
    • 11.1.3 ABBOTT LABORATORIES
    • TABLE 115 ABBOTT LABORATORIES: BUSINESS OVERVIEW
    • FIGURE 32 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2022)
    • 11.1.4 SIEMENS HEALTHCARE GMBH
    • TABLE 116 SIEMENS HEALTHCARE GMBH: BUSINESS OVERVIEW
    • FIGURE 33 SIEMENS HEALTHCARE GMBH: COMPANY SNAPSHOT (2022)
    • 11.1.5 THERMO FISHER SCIENTIFIC INC.
    • TABLE 117 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
    • FIGURE 34 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)
    • 11.1.6 HORIBA, LTD.
    • TABLE 118 HORIBA, LTD.: BUSINESS OVERVIEW
    • FIGURE 35 HORIBA, LTD.: COMPANY SNAPSHOT (2022)
    • 11.1.7 SYSMEX CORPORATION
    • TABLE 119 SYSMEX CORPORATION: BUSINESS OVERVIEW
    • FIGURE 36 SYSMEX CORPORATION: COMPANY SNAPSHOT (2022)
    • 11.1.8 EKF DIAGNOSTICS
    • TABLE 120 EKF DIAGNOSTICS: BUSINESS OVERVIEW
    • FIGURE 37 EKF DIAGNOSTICS: COMPANY SNAPSHOT (2022)
    • 11.1.9 QUIDELORTHO CORPORATION
    • TABLE 121 QUIDELORTHO CORPORATION: BUSINESS OVERVIEW
    • FIGURE 38 QUIDELORTHO CORPORATION: COMPANY SNAPSHOT (2022)
    • 11.1.10 HITACHI LTD.
    • TABLE 122 HITACHI LTD.: BUSINESS OVERVIEW
    • FIGURE 39 HITACHI LTD.: COMPANY SNAPSHOT (2022)
  • 11.2 OTHER PLAYERS
    • 11.2.1 MINDRAY MEDICAL INTERNATIONAL LTD.
    • 11.2.2 ELITECH GROUP
    • 11.2.3 BIOBASE GROUP
    • 11.2.4 SFRI
    • 11.2.5 TRIVITRON HEALTHCARE PVT. LTD.
    • 11.2.6 RANDOX LABORATORIES LTD.
    • 11.2.7 MEDICA CORPORATION
    • 11.2.8 MERIL LIFE SCIENCES PVT. LTD.
    • 11.2.9 ERBA MANNHEIM
    • 11.2.10 GENRUI BIOTECH CO., LTD.
    • 11.2.11 DIRUI
    • 11.2.12 TECO DIAGNOSTICS
    • 11.2.13 BALIO DIAGNOSTICS
    • 11.2.14 SNIBE CO. LTD.
    • 11.2.15 AMS ALLIANCE
  • *Details on Business overview, Products offered, Recent developments, Product launches, MnM view, Key strengths, Strategic choices, and Weaknesses & competitive threats might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS